Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D06WJK
|
|||
Drug Name |
US10034861, Example 164
|
|||
Synonyms |
SCHEMBL19762485; BDBM279133; US10034861, Example 164; 5-(2-ethoxy-3-pyridyl)-1-isopropyl-3-methyl-7-[(1-methylpyrazol-4-yl)methylsulfanyl]pyrazolo[4,3-b]pyridine
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Structure |
Download2D MOL |
|||
Formula |
C24H32N4O3S
|
|||
Canonical SMILES |
CCOC1=C(C=CC=N1)C2=NC3=C(C(=C2)SCCC(=O)OCC(C)C)N(N=C3C)C(C)C
|
|||
InChI |
1S/C24H32N4O3S/c1-7-30-24-18(9-8-11-25-24)19-13-20(32-12-10-21(29)31-14-15(2)3)23-22(26-19)17(6)27-28(23)16(4)5/h8-9,11,13,15-16H,7,10,12,14H2,1-6H3
|
|||
InChIKey |
HVDCJFCTBUPVCE-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Phosphodiesterase 1B (PDE1B) | Target Info | Inhibitor | [1] |
Target's Patent Info | Phosphodiesterase 1B (PDE1B) | Target's Patent Info | [1] | |
KEGG Pathway | Purine metabolism | |||
Calcium signaling pathway | ||||
Morphine addiction | ||||
Reactome | cGMP effects | |||
G alpha (s) signalling events | ||||
WikiPathways | G Protein Signaling Pathways | |||
DAG and IP3 signaling | ||||
Opioid Signalling |
References | Top | |||
---|---|---|---|---|
REF 1 | 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors. US10034861. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.